{"nct_id":"NCT02510261","title":"The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Participants Who Have Already Been Treated With ALN-TTR02 (Patisiran)","status":"COMPLETED","status_verified_date":"2023-11","start_date":"2015-07-16","start_date_type":"ACTUAL","primary_completion_date":"2022-11-23","primary_completion_date_type":"ACTUAL","completion_date":"2022-11-23","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ALNY"]}